GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cellsStyliani Karanika, Timothy C. Thompson|Molecular Cancer|2015Cited by 28
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLNour Sabiha Naji, Theodoros Karantanos, Evangeline Watson et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
CCRL2 As a Novel Target in Acute Erythroid LeukemiaNour Sabiha Naji, Theodoros Karantanos, Taha Ahmedna et al.|Blood|2024Cited by 0
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLTheodoros Karantanos, Suman Paul, Nour Sabiha Naji et al.|Research Square|2025Cited by 0